Di Nisio M, van Es N, Büller HR. Deep vein thrombosis and pulmonary embolism. Lancet. 2016;388(10063):3060–73.

Article  PubMed  Google Scholar 

Deitelzweig SB, Johnson BH, Lin J. Prevalence of clinical venous thromboembolism in the USA:current trends and future projections. Am J Hematol. 2011;86(2):217–9.

Article  CAS  PubMed  Google Scholar 

Huang W, Goldberg RJ, Anderson FA, Kiefe CI, Spencer FA. Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985–2009). Am J Med. 2014;127(9):829–839e5.

Article  PubMed  PubMed Central  Google Scholar 

Konstantinides SV, Meyer G, Bueno H, Galié N, Gibbs JSR, et al. 2019 ESC guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European respiratory society (ERS). Eur Heart J. 2020;41(4):543–603.

Article  PubMed  Google Scholar 

Ortel TL, Neumann I, Ageno W, Beyth R, Clark NP, et al. American society of hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism. Blood Adv. 2020;4(19):4693–738.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Søgaard KK, Schmidt M, Pedersen L, Horváth-Puhó E, Sørensen HT. 30-Year mortality after venous thromboembolism a population-based cohort study. Circulation. 2014;130(10):829–36.

Article  PubMed  Google Scholar 

Faller N, Limacher A, Méan M, Righini M, Aschwanden M, et al. Predictors and causes of Long-Term Mortality in Elderly patients with acute venous thromboembolism: a prospective cohort study. Am J Med. 2017;130(2):198–206.

Article  PubMed  Google Scholar 

Kraaijpoel N, Tritschler T, Guillo E, Girard P, Le Gal G. Definitions, adjudication, and reporting of pulmonary embolism–related death in clinical studies: a systematic review. J Thromb Haemost. 2019;17(10):1590–607.

Article  PubMed  Google Scholar 

Klemen ND, Feingold PL, Hashimoto B, Wang M, Kleyman S, Brackett A, et al. Mortality risk associated with venous thromboembolism: a systematic review and bayesian meta-analysis. Lancet Haematol. 2020;7(8):e583–93. 016/S.

Article  PubMed  Google Scholar 

Tagalakis V, Patenaude V, Kahn SR, Suissa S. Incidence of and mortality from venous thromboembolism in a real-world population: The Q-VTE study cohort. Am J Med. 2013;126(9):832.e13-832.e21.

Kearon C, Ageno W, Cannegieter SC, Cosmi B, Geersing GJ, et al. Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor. Arch Intern Med. 2010;170(19):1710–6.

PubMed  Google Scholar 

Raskob GE, Angchaisuksiri P, Blanco AN, Buller H, Gallus A, et al. ISTH Steering Committee for World thrombosis day. Thrombosis: a major contributor to global disease burden. Arterioscler Thromb Vasc Biol. 2014;34(11):2363–71.

Article  CAS  PubMed  Google Scholar 

Roetker NS, Lutsey PL, Zakai NA, Alonso A, Adam TJ, et al. All-cause mortality risk with direct oral anticoagulants and warfarin in the primary treatment of venous thromboembolism. Thromb Haemost. 2018;118(9):1637–45.

Article  PubMed  PubMed Central  Google Scholar 

Bounameaux H, Haas S, Farjat AE, Ageno W, Weitz JI, Goldhaber SZ, et al. Comparative effectiveness of oral anticoagulants in venous thromboembolism: GARFIELD-VTE. Thromb Res. 2020;191(March):103–12.

Article  CAS  PubMed  Google Scholar 

Næss IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5(4):692–9.

Article  PubMed  Google Scholar 

Arshad N, Bjøri E, Hindberg K, Isaksen T, Hansen JB, Brækkan SK. Recurrence and mortality after first venous thromboembolism in a large population-based cohort. J Thromb Haemost. 2017;15(2):295–303.

Article  CAS  PubMed  Google Scholar 

Gussoni G, Frasson S, La Regina M, Di Micco P, Monreal M. Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. Thromb Res. 2013;131(1):24–30.

Article  CAS  PubMed  Google Scholar 

Gómez-Outes A, Lecumberri R, Suárez-Gea ML, Terleira-Fernández AI, Monreal M, et al. Case Fatality Rates of recurrent thromboembolism and bleeding in patients receiving direct oral anticoagulants for the initial and extended treatment of venous thromboembolism. J Cardiovasc Pharmacol Ther. 2015;20(5):490–500.

Article  PubMed  Google Scholar 

Sørensen HT, Mellemkjaer L, Olsen JH, Baron JA. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343(25):1846–50.

Article  PubMed  Google Scholar 

Socialstyrelsen. Statistical Database, Cause of Death [Internet]. 220622. 2022. Available from: https://sdb.socialstyrelsen.se/if_dor/val_eng.aspx.

Brooke HL, Talbäck M, Hörnblad J, Johansson LA, Ludvigsson JF, Druid H, et al. The Swedish cause of death register. Eur J Epidemiol. 2017;32(9):765–73.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pollack CV, Schreiber D, Goldhaber SZ, Slattery D, Fanikos J, et al. Clinical characteristics, management, and outcomes of patients diagnosed with acute pulmonary embolism in the emergency department: initial report of EMPEROR (multicenter emergency medicine pulmonary embolism in the real world registry). J Am Coll Cardiol [Internet]. 2011;57(6):700–6.

Article  PubMed  Google Scholar 

Chwan Ng AC, Chung T, Yong ASC, Wong HSP, Celermajer DS, et al. Long-term cardiovascular and noncardiovascular mortality of 1023 patients with confirmed acute pulmonary embolism. Circ Cardiovasc Qual Outcomes. 2011;4(1):122–8.

Article  Google Scholar 

Becattini C, Vedovati MC, Ageno W, Dentali F, Agnelli G. Incidence of arterial cardiovascular events after venous thromboembolism: a systematic review and a meta-analysis. J Thromb Haemost. 2010;8(5):891–7.

Article  CAS  PubMed  Google Scholar 

Mi Y, Yan S, Lu Y, Liang Y, Li C. Venous thromboembolism has the same risk factors as atherosclerosis. Med (Baltim). 2016;95(32):e4495.

Article  CAS  Google Scholar 

Barco S, Mahmoudpour SH, Valerio L, Klok FA, Münzel T, et al. Trends in mortality related to pulmonary embolism in the European Region, 2000–15: analysis of vital registration data from the WHO Mortality Database. Lancet Respir Med. 2020;8(3):277–87.

Article  PubMed  Google Scholar 

Wallerstedt SM, Wettermark B, Hoffmann M. The First Decade with the Swedish Prescribed Drug Register-A Systematic Review of the output in the scientific literature. Basic Clin Pharmacol Toxicol. 2016;119(5):464–9.

Article  CAS  PubMed  Google Scholar 

Fastbom J, Johnell K. National indicators for quality of drug therapy in older persons: the Swedish experience from the first 10 years. Drugs Aging. 2015;32:189–99.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wallerstedt SM, Belfrage B, Fastbom J. Association between drug specific indicators of prescribing quality and quality of drug treatment: a validation study. Pharmacoepidemiol Drug Saf. 2016;24:906–14.

Article  Google Scholar 

Öhman L, Johansson M, Jansson JH, Lind M, Johansson L. Positive predictive value and misclassification of diagnosis of pulmonary embolism and deep vein thrombosis in Swedish patient registries. Clin Epidemiol. 2018;10:1215–21.

Article  PubMed  PubMed Central  Google Scholar